Pharmaceutical Industry Reports plasminogen activator inhibitor market | Page 4

REPORT DESCRIPTION
Plasminogen Activator Inhibitor Market – Key Players





Bayer AG
SteadyMed Ltd
GlaxoSmithKline plc
Pfizer Inc., Abcam plc
ARUP Laboratories
Increasing product recall due to variations in the PAI kits is responsible for uneven results which is
affecting the growth of plasminogen activator inhibitor market. For instance, in July 2016, U.S. Food and
Drug Administration (USFDA) recalled IMUBIND Plasma PAI-1 Enzyme Linked Immunosorbant Assay
(ELISA) kits manufactured by American Diagnostica, Inc. The recall was initiated due to unacceptable
microwell to microwell variation in the section of the ELISA plates that is typically used for the calibrators.
This product affected the reproducibility of the results which can restrain the market.
Read More @
https://www.coherentmarketinsights.com/ongoing-insight/plasminogen-activator-inhibitor-market-2288